Explorer les evidences

92,2 %In 2015, Burkina Faso reported a monthly seasonal malaria chemoprevention coverage rate of 92.2%.

Burkina Fasopaludismeobservé 2015HAL · Unilimdocument de 110 observations

45,1 %Vaccine efficacy of RTS,S/AS01 against severe malaria was 45.1% in the intention-to-treat population.

Burkina Fasopaludismepublié 2011The New England journal of medicineeurope_pmcdocument de 7 observationsDOI 10.1056/nejmoa1102287

45,2 %The prevalence of ESBL-producing Enterobacterales was 45.2% (14/31) in Burkina Faso.

Burkina FasoESBL-producing Enterobacteralesobservé November 2013 to March 2017publié 2020Frontiers in microbiologyeurope_pmcdocument de 12 observations

38,6 %Of the 57 patients who were febrile on examination, 22 had malaria, representing 38.6%.

Burkina FasopaludismeHAL · Unilimdocument de 83 observations

3,26 odds_ratioHeterozygote males were more competitive than homozygote susceptible males, with an odds ratio of 3.26 and P = 0.006.

Burkina Fasopaludismepublié 2015Heredityeurope_pmcdocument de 6 observations

22,6 %Of the 306 patients, 69 were diagnosed with malaria, representing 22.6%.

Burkina FasopaludismeHAL · Unilimdocument de 83 observations

0,4 proportionThe allele frequency of the L1014S kdr mutation conferring resistance to pyrethroids was 0.4.

Burkina Fasopaludismepublié 2017PloS oneeurope_pmcdocument de 7 observations

7 foldPatients with acute malaria or recovering from malaria had a 7-fold higher risk of presenting polymicrobial bloodstream infections compared to patients with no recent malaria diagnosis.

Burkina Fasopaludisme · polymicrobial bloodstream infectionspublié 2016PLoS neglected tropical diseaseseurope_pmcdocument de 4 observations

23,4 %Of the 73,101 female Anopheles mosquitoes collected, 23.4% (17,083) were captured using CDC_LT.

Burkina Fasopaludismeobservé July 28, 2019 to February 27, 2022HAL · Unilimdocument de 87 observations

11,11 %The prevalence of hepatitis B virus infection in pregnant women in Burkina Faso was 11.11% after adjustment.

Burkina Fasohépatite Bpublié 2018BMC public healtheurope_pmcdocument de 12 observationsDOI 10.1186/s12889-018-5432-7

2,2 %HCV and HBV coinfection was 2.2% among the 462 screened patients at Saint Camille Medical Centre.

Burkina Fasohépatite B · hépatite Cobservé 2012publié 2012Pakistan journal of biological sciences : PJBSeurope_pmcdocument de 8 observations

11,7 %The acquisition of immunity against HBV after vaccination was attempted for 11.7% of the screened patients at Saint Camille Medical Centre.

Burkina Fasohépatite Bobservé 2012publié 2012Pakistan journal of biological sciences : PJBSeurope_pmcdocument de 8 observations

84,9 %At day 28, the PCR-corrected adequate clinical and parasitological response (ACPR) was 84.9% in the intention-to-treat population receiving the crushed-tablet formulation of dihydroartemisinin/piperaquine phosphate.

Burkina Fasopaludismepublié 2018Antimicrobial agents and chemotherapyeurope_pmcdocument de 10 observations

2,6 per_1000Neonatal mortality rate ranged from 2.6 to 41.6 per 1000 live births.

Burkina Fasomortalité néonataleobservé 2009 to 2014publié 2019International journal of public healtheurope_pmcdocument de 7 observations

2,58 odds_ratioHeterozygote RDL(R)/RDL(S) males were more likely to mate than homozygote-resistant males, with an odds ratio of 2.58 and P = 0.007.

Burkina Fasopaludismepublié 2015Heredityeurope_pmcdocument de 6 observations

44,4 %Of 3170 participants, 44.4% in the passive surveillance group reported at least one adverse event after use of artemisinin-based combination therapies.

Burkina Fasopaludismeobservé 2010–2012publié 2020Drug design, development and therapyeurope_pmcdocument de 5 observations

3,62 %Mixed-species pairs captured in copula made up 3.62% of mating pairs involving An. coluzzii individuals.

Burkina Fasopaludismepublié 2015Parasites & vectorseurope_pmcdocument de 4 observationsDOI 10.1186/s13071-015-1190-x

27 %A phase 3 clinical trial of RTS,S/AS01 across eleven sub-Saharan African sites demonstrated a vaccine efficacy against clinical malaria of approximately 27% in infants aged 6–12 weeks.

Burkina FasopaludismeHAL · Unilimdocument de 39 observations

The prevalence of HIV seropositivity among young women is higher than for men of the same age in all included Demographic and Health Surveys except for the Burkina Faso DHS.

Burkina FasoVIH/sidapublié 2021Journal of global healthPubMeddocument de 4 observations

17,8 %Using culture, Streptococcus pneumoniae (Spn) accounted for 17.8% of purulent meningitis cases.

Burkina Fasoméningite bactérienneobservé 2009–2010publié 2013Medecine et sante tropicaleseurope_pmcdocument de 9 observations

11 %The attributable fraction of fever to malaria was 11% in the dry season in Burkina Faso.

Burkina Fasopaludismeobservé dry seasonpublié 2010Malaria journaleurope_pmcdocument de 20 observationsDOI 10.1186/1475-2875-9-192

CSST/IPTp-SP interacted with birth season and gravidity to reduce the incidence of nonmalarial fevers.

Burkina Fasononmalarial feverspublié 2018The Journal of infectious diseaseseurope_pmcdocument de 3 observationsDOI 10.1093/infdis/jiy140

25,3 titerAt day 180, the PfCSP-specific geometric mean titer (GMT) was 25.3 in the ProC6C-AlOH/Matrix-M group.

Burkina Fasopaludismeobservé D180HAL · Unilimdocument de 39 observations

1 280 casesIn 2023, simple malaria among children under 5 years in the Koudougou health district accounted for 1280 cases and represented 50.01% of malaria cases.

Burkina Fasopaludismeobservé 2023HAL · Unilimdocument de 110 observations

8,4 %La fréquence de la neuropathie périphérique était de 8,4 % chez les personnes vivant avec le VIH au Burkina Faso selon l'étude de Millogo A et al (2008).

Burkina FasoVIH/sidaobservé 2008HAL · Unilimdocument de 747 observations